about
High-throughput profiling of anti-glycan humoral responses to SIV vaccination and challengeHumoral response to a viral glycan correlates with survival on PROSTVAC-VFSugar-binding proteins from fish: selection of high affinity "lambodies" that recognize biomedically relevant glycans.Competition between serum IgG, IgM, and IgA anti-glycan antibodiesEnhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine.Evaluation of riproximin binding properties reveals a novel mechanism for cellular targetingGlycan array analysis of the antigen repertoire targeted by tumor-binding antibodiesFactors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum.ABO blood type correlates with survival on prostate cancer vaccine therapySerum antibodies to blood group A predict survival on PROSTVAC-VF.Diverse molecular recognition properties of blood group A binding monoclonal antibodies.Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.Development and validation of a Luminex assay for detection of a predictive biomarker for PROSTVAC-VF therapy.Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses.Whole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins.Therapeutic Antibodies to Ganglioside GD2 Evolved from Highly Selective Germline Antibodies.Enterotoxigenic Escherichia coli blood group A interactions intensify diarrheal severity.
P2860
Q30354064-D7A92339-8CE6-4485-95E8-056F355C5C0AQ33674367-1F642B59-BBC1-4711-A9CA-5954771B0933Q34431854-A1423C4D-6BD9-4CE3-B71C-0D5F9D4F6BEDQ35217313-B3BBDC46-5974-4075-8434-A3569A393924Q36302781-5532B17A-4D03-471A-AD61-7368AAD95517Q36332756-0D860B14-B5C4-4833-AF53-810C17B8DEB5Q36340501-2139233D-676D-4D84-A7FB-EED9327C45B9Q36499916-31B05F0E-497D-464D-ABA3-8845F42691B8Q36544831-2AB4DC23-AA7C-449F-8343-9381213F8B01Q36674798-A2768AA9-3160-48E6-B1FF-8C21AD9A0320Q36745220-1CE75E9E-E904-417D-9804-E030F949B5EEQ37033066-A5FE482B-71B9-401E-8E82-177F49F6B663Q41238074-F76F0D1F-2845-470B-967D-4CF11BE6690BQ46202850-CBCB39A6-1031-4204-932C-5A9025078BB0Q46767596-8113B57B-392B-4A10-9E92-922721EB19EEQ47945436-84FF1F61-8920-4AEF-98CF-B9ADD6C7B48FQ54201990-335E42B9-BF1C-4CFC-8514-EEC03D81E118
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Construction and use of glycan microarrays.
@ast
Construction and use of glycan microarrays.
@en
type
label
Construction and use of glycan microarrays.
@ast
Construction and use of glycan microarrays.
@en
prefLabel
Construction and use of glycan microarrays.
@ast
Construction and use of glycan microarrays.
@en
P2093
P2860
P1476
Construction and use of glycan microarrays.
@en
P2093
Christopher T Campbell
Jeffrey C Gildersleeve
Yalong Zhang
P2860
P356
10.1002/9780470559277.CH090228
P577
2010-03-01T00:00:00Z